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Abstract
Summary Reference point indentation is a novel method
to assess bone material strength index (BMSi) in vivo.
We found that BMSi at the mid-tibia was weakly asso-
ciated with spine and hip areal bone mineral density but
not with prevalent fracture in a population-based cohort
of 211 older women.
Introduction Reference point indentation is a novel method to
assess BMSi in vivo. Lower BMSi has been observed in patients
with prior fracture than in controls, but no association between
BMSi and areal bone mineral density (aBMD) has been found.
Population-based association studies and prospective studies
with BMSi and fractures are lacking. We hypothesized that
BMSi would be associated with prevalent fractures in older
Swedish women. The aim was to investigate the associations
between BMSi, aBMD, and prevalent fracture in older women.
Methods Two hundred eleven women, mean age 78.3±
1.1 years, were included in this cross-sectional, population-
based study. BMSi was assessed using the OsteoProbe device
at the mid-tibia. Areal BMD of the hip, spine, and non-
dominant radius was measured using dual-energy X-ray ab-
sorptiometry (DXA). Fracture history was retrieved using
questionnaires, and vertebral fractures were identified using
vertebral fracture assessment (VFA) by DXA.
Results One hundred ninety-eight previous fractures in 109 sub-
jects were reported. A total of 106 women had a vertebral frac-
ture, of which 58 women had moderate or severe fractures. An
inverse correlation between BMSi and weight (r=−0.14, p=
0.04) was seen, and BMSi differed according to operator
(ANOVA p<0.01). Adjusting for weight and operator in a linear
regression model, we found that BMSi was positively associated
with aBMD of the total hip (β=0.14, p=0.04), non-dominant
radius (β=0.17, p=0.02), and lumbar spine (L1–L4) (β=0.14,
p<0.05). Using logistic regression, we could not find any asso-
ciation in crude or adjusted BMSi (for age, weight, height, walk-
ing speed, calcium intake, smoking, bisphosphonate and gluco-
corticoid use, and operator) with prevalent fractures.
Conclusion We conclude that BMSi is associated with aBMD
but not with prevalent fracture in a population-based cohort of
211 older women.
Keywords Bonematerial strength . Bonemineral density .
Fracture
Introduction
Osteoporotic fractures constitute a major public health problem
in Sweden, in which every second women and fifth man after
age 50 years will suffer from such a fracture [1]. Bone mineral
density (BMD), as derived by dual-energy X-ray absorptiometry
(DXA), is a well-studied predictor of fracture risk and used as the
golden standard to diagnose osteoporosis and determine fracture
risk today [2]. Osteoporosis, defined as BMD≤−2.5 SD below
the mean value of a young adult population, does however not
alone explain fracture risk, sincemany fractures occur in patients
with normal BMD and not all patients with low bone mass do
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fracture [3]. Other clinical risk factors, such as advanced age,
prior fracture, heredity, smoking, and medications such as oral
glucocorticoids, contribute independently to fracture risk [4,
5]. Also, geometrical and microarchitectural properties as
well as more sophisticated assessment of bone strength by
finite element analyses are associated with fractures, partially
independent of BMD [6, 7]. Recently, much interest has
been given material strength properties of the bone, as mea-
sured with non-imaging techniques. Reference point indenta-
tion (RPI) is a novel such method for assessment of bone
material strength index (BMSi) in vivo [8]. The method
includes a device with a needle being pushed with a defined
force on the bone surface, and the outcome measure is the
distance the needle is pushed into the bone or indentation
distance increase (IDI). IDI determined with one RPI instru-
ment, the BioDent (ActiveLife Tech, Inc., CA, USA), has
been shown to be able to discriminate between controls
without fracture and cases with either osteoporotic fractures
[8], osteoporotic hip fractures, or atypical hip fractures [9].
The BioDent and other previous RPI devices included a
reference probe and required displacement of the periosteum
before the indentation procedure. The most recently intro-
duced RPI device, the OsteoProbe (Active Life Scientific
Inc., CA, USA), requires no reference probe and can be used
through the soft tissue and periosteum, which makes it easy to
operate and does not require extensive training according to
the manufacturer [10, 11]. The OsteoProbe measures BMSi,
which is a unitless parameter, derived as the ratio between the
average IDI (of repeated measurements) in a reference stan-
dard of polymethylmetacrylate (PMMA) and in the bone. So
far, only one study has investigated the associations between
prevalent fractures and BMSi derived by the OsteoProbe. In a
study on 90 men and women (40.4–85.5 years) with low bone
mass, Malgo et al. demonstrated an inverse association be-
tween BMSi and prevalent fragility fractures, independent of
areal BMD [12]. The microindentation-derived BMSi is be-
lieved to describe a bone component different fromBMD, and
other studies using the OsteoProbe have not reported any as-
sociation with DXA-derived areal BMD (aBMD). Farr et al.
showed that diabetic subjects had approximately 10 % lower
BMSi than age-matched controls, also after adjustment for
BMI, while aBMD did not differ between the groups after
BMI adjustment [13]. Furthermore, a study comparing 42
Norwegian and 46 Spanish women demonstrated lower BMSi
and higher BMD in the Norwegian women as compared to the
Spanish women [14].
The aim of this study was to investigate the associations
between BMSi and prevalent fractures, including vertebral
fractures (defined by vertebral fracture assessment (VFA),
with DXA), in a population-based cohort of 211 women
between 75 and 80 years of age. Furthermore, we
sought to examine possible associations between BMSi
and DXA-derived aBMD in the same cohort.
Materials and methods
A population-based study of older women, 75 and 80 years of
age, was initiated in 2013 with the aim to determine predictors
of hip and other fractures. Women were identified using na-
tional population registers, contacted by mail and telephone,
and asked to participate in the study. Women had to be able to
understand Swedish and walk (with or without an aid) to be
eligible for the study. From September 2014 to March 2015,
all participating women (n=496) were considered for partici-
pation in the present study. Of these, a total of 482 subjects
were contacted by telephone and asked to participate in the
BMSi exam. One study participant declined any further stud-
ies at first visit, one had extensive osteosynthesis material of
the lower limbs, three subjects could not be reached, seven
had leg ulcers, and two were under cytostatic treatment and
currently immunodeficient and were therefore excluded. Of
the contacted subjects, 218 agreed to participate in the study,
corresponding to 45.2% of the initially contacted.Written and
oral consent was obtained from all study participants. The
Regional Ethical Review Board at the University of Gothen-
burg approved the study.
Height and weight were measured using standardized
equipment. As a measure of current physical fitness, the sub-
jects were instructed to walk a 10-m distance in their self-
chosen pace. This was conducted twice, and the mean time
was used to calculate walking speed (m/s). Calcium intake
was estimated from reported daily intake of dairy products
including contingent medical calcium supplementation and
expressed in mg/day.
Bone mineral density
aBMD (g/cm2) of the total hip, femur neck, lumbar spine, and
the mid-third of the non-dominant radius were assessed using
DXA (Discovery A, Hologic). aBMD of the lumbar spine was
calculated as the mean of L1–L4, excluding fractured verte-
brae. T scores were generated by the DXA software (version
13.1.0) using the manufacturer-specific database. The coeffi-
cient of variation (CV) for aBMD of the total hip was 0.83 %,
femur neck 1.3 %, lumbar spine 0.68 %, and radius 3.1 %.
CVs for the spine and hip (including neck) measurements
were obtained by duplicate measurements on 30 women,
75–80 years old, while the radius CVwas obtained using three
measurements on one woman. One operator performed all
measurements.
Bone material strength
BMSi was assessed using the OsteoProbe® (Active Life Sci-
entific Inc., CA, USA), which is a RPI device developed for
microindentation in vivo [10, 11]. The OsteoProbe® is a hand-
held instrument with a needle of stainless steel with a trigger
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mechanism, allowing testing on the anterior face of the mid-
tibia under local anesthesia (2 ml, mepivacaine, 10 mg/ml).
The needle is applied through the skin and firmly pushed
perpendicular to the bone surface (Fig. 1). When the load/
force reaches 10N, a trigger mechanismwill initiate an impact
where the needle will be pushed into the bone surface with a
force of 30 N during less than a millisecond. This will create
an indentation, or microfracture, on the bone surface. The
software registers the distance from the needle tip right before
impact and right after, a distance called the IDI. Directly after a
number of repeated measurements separated from one another
by at least 2 mm, five measurements are performed on a piece
of PMMA. The BMSi is calculated as 100 times the ratio of
the mean IDI in the PMMA and the tibia.
In the present study, at least 11 valid indentations were
performed on each subject, of which the first indentation (per-
forating the skin) was discarded since the probe is not
established on the bone and the indentation value is affected
by amount and toughness of soft tissue and skin. All other
indentations were checked for validity, and indentations that
for obvious technical reasons failed were deleted. Of the 218
subjects who agreed to participate in the study, a total of 7
subjects had to be excluded, due to failed indentations. Out of
these seven subjects, six of them were excluded because of
difficulties acquiring enough number of indentations second-
arily to firm or large amount of subcutaneous tissue or due to
marked irregularities on the tibial surface. In one subject, the
measurement was cancelled before it had started because of
discomfort for the patient during the application of local an-
esthesia. Thus, in all, 211 subjects were included in the sub-
sequent analyses.
The measurements were performed by four operators, and
in the first 100 measurements, there were at least two opera-
tors present, to assure that all operators performed the proce-
dure uniformly. The first 100 subjects were contacted by tele-
phone 3 days after the procedure, and no adverse events were
reported.
The intraobserver CV for the method was 3.2 %, which
was calculated bymeasuring 30 subjects twice. Bothmeasure-
ments were made by the same operator, on the same leg with
an approximately 2-cm distance between the two measure-
ment sites, including a short break between the measurements
where the indentation needle was exchanged for a new needle.
The reported CV corresponds to the mean of the CVs of each
of the 30 paired measurements, calculated as 100 times the
ratio between the SD and the mean. Interobserver CV was
5.2 %, which was calculated measuring another set of 30
subjects in the same manner as previously described but with
two different operators performing the first and second mea-
surement. All four operators participated in the assessments of
both CVs. Each subject was measured by one operator, except
for in 30 subjects who were measured by two different oper-
ators in order to calculate interobserver CV.
After analyzing all BMSi measurements, we found that the
means were significantly different between the four operators
(operator 1 (n=36) 75.7±7.8 (mean±SD), operator 2 (n=41)
75.3±8.1, operator 3 (n=60) 79.4±7.0, and operator 4 (n=74)
72.6±6.3, ANOVA p<0.001). To adjust for operator in the
present study, we used dummy variables as independent var-
iables in the linear and logistic regression models.
Fracture history
Fracture history was retrieved by a questionnaire, and subjects
were asked to report fracture site and their age at the time of
the fracture. Peripheral fractures were defined as fractures of
the limbs (excluding feet and hands), i.e., radius, ulna, humer-
us, tibia, fibula, and the femur. Osteoporotic fractures were
defined by skeletal site as fractures of the distal forearm, prox-
imal humerus, vertebral fractures, hip fractures, and pelvic
fractures. All reported fractures after the age of 50 years were
included in the analyses. Thus, the control group in Table 2
(no fracture) refers to no fractures after the age of 50 years. All
fractures, irrespective of trauma type, were included.
Vertebral fractures were identified using VFA by DXA
[15], where fractures were classified according to the semi-
quantitative method of Genant [16]. A lateral scan of the DXA
was used to visually detect morphologic deformities of the
vertebrae, and by measurement of the anterior, middle, and
posterior aspects of the vertebrae, detected fractures were
graded due to their height reduction as mild (20–25 %), mod-
erate (25–40 %), or severe (>40 %). The morphology of ad-
jacent vertebrae was also taken into account when diagnosing
vertebral compressions. The same physician evaluated allFig. 1 Performing microindentations using the OsteoProbe
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lateral DXA scans. In the present study, only moderate and
severe vertebral fractures were accounted for as prevalent frac-
tures whereas subjects with only mild fractures were excluded
from further analysis. The operator’s reproducibility was test-
ed on 550 vertebras. For vertebras T4–L4, the intraobserver
agreement was 98.9 % (kappa score 0.85) and the interobserv-
er agreement was 97.6 % (kappa score 0.72). When mild
vertebral fractures were excluded, the intraobserver agreement
was 100 % (kappa score 1.0) and the interobserver agreement
was 99.6 % (kappa score 0.95).
Statistical analyses
Correlations between BMSi and anthropometrics, environ-
mental factors, and DXA measurements were investigated
by Pearson correlation test. Associations between aBMD var-
iables and BMSi were evaluated with linear regressionmodels
including weight and dummy variables for operator as inde-
pendent variables in the first analysis and also including all
other covariates in the second analysis. Evaluation of BMSi in
relation to smoking, bisphosphonate and glucocorticoid use,
and fracture history was made by independent samples t test.
In the latter analysis, weight and operator-adjusted BMSi was
used, which was calculated using linear regression, where the
unstandardized residuals were added to the mean value to
achieve adjusted values of BMSi. Logistic regression models,
including all covariates, were used to determine whether
BMSi was associated with fracture or not. Weight was not
normally distributed, as observed also in other populations
[17, 18] and therefore log-transformed before inclusion in
the statistical models. P values less than 0.05 were considered
significant. All analyses were performed using SPSS (Version
20, SPSS, Inc., Chicago, IL, USA).
Results
A total of 211 subjects were included in the present study. The
mean value of the BMSi measurements was 75.6±7.6 with a
range from 52.9 to 93.3. Other characteristics of the subjects,
including age, anthropometrics, environmental factors, and
aBMD, are presented in Table 1.
Correlations between BMSi, anthropometrics, aBMD,
and medication use
Crude BMSi was inversely correlated to weight, but no corre-
lations were seen with age, height, walking speed, calcium
intake, or any of the aBMD measurements (Table 1). There
were no significant differences in BMSi between smokers and
non-smokers, or ever smokers and never smokers, respective-
ly. No differences were seen between current users of
bisphosphonates or glucocorticoids and non-users,
respectively, but ever users of bisphosphonates had slightly
higher BMSi (although only borderline significant) than never
users, which was not the case for ever glucocorticoid-treated
subjects (Table 2). Using BMSi adjusted for weight and oper-
ator did not significantly alter these results, except for the
difference between ever and never users of bisphosphonates,
which was no longer borderline significant.
BMSi and the association with aBMD
Using a linear regression model with aBMD as dependent var-
iable and crude BMSi, weight, and operator dummy variables
as independent variables, we found that BMSi was positively
associated with aBMD of the total hip, femur neck, lumbar
spine, and the radius (Table 1). After also including age, height,
walking speed, calcium intake, smoking status, and use of
bisphosphonates and glucocorticoids as covariates, only aBMD
of the radius remained significant, whereas aBMD of the hip
and lumbar spine were of borderline significance (Table 1).
BMSi and the absence of association with prevalent
fractures
A total of 198 fractures in 109 subjects were reported in the
questionnaire. Of these, there were 86 subjects with fractures
that occurred after the age of 50. Using VFA by DXA, we
found a total of 176 deformed vertebrae in 106 subjects,
interpreted as prevalent vertebral fractures, of which 91 were
mild, 57 moderate, and 28 severe. A total of 58 women had
moderate and/or severe vertebral fractures, whereas 48 sub-
jects only had mild fractures. Of these 48 subjects, a total of 31
had no other reported fractures and were therefore excluded
from further analyses. Including all reported fractures after the
age of 50 and all moderate and severe VFA-verified vertebral
fractures, there were 117 women who were assigned to the
fracture group and 63 subjects with no reported fractures or no
significant vertebral deformities were used as controls in the
following analyses.
There were no differences in either crude or weight and
operator-adjusted BMSi between the fracture group and the con-
trols, but aBMD at the hip was significantly lower in the former
group (Table 3). Women with VFA-verified vertebral fractures
(n=58) had lower aBMD of the hip than the controls, but no
difference was seen in BMSi. Reported peripheral (n=53) and
osteoporotic (n=89) fractures occurring after the age of 50
showed a similar pattern with no differences in BMSi but lower
aBMD at the hip and for peripheral fractures also at the lumbar
spine. Subjects with peripheral fractures after the age of 50 had
slightly higher calcium intake than the controls (Table 3).
Inc luding current use of glucocor t icoids and
bisphosphonates, smoking, age, height, weight, calcium intake,
operator, and walking speed as independent variables together
with BMSi in a logistic regression model, we found no
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associations between BMSi and any prevalent fracture, verte-
bral fractures, peripheral fractures, or osteoporotic fractures
(Table 4). Including also ever users of glucocorticoids and
bisphosphonates did not change the outcome of these analyses
(data not shown). On the other hand, areal BMD of the hip
showed strong associations with all subgroups of fractures,
which was also the case for lumbar spine aBMD regarding
peripheral fractures (Table 4).
BMSi in osteopenic/osteoporotic subjects
Osteopenic/osteoporotic subjects (femur neck T score≤−1, n=
176) had no different BMSi than subjects with normal aBMD
(n=35) (75.6±7.6 vs. 75.5±7.6, p=0.93) nor were there any
significant differences in weight or operator-adjusted BMSi
between osteopenic/osteoporotic subjects and subjects with
normal aBMD (75.4±7.0 vs. 76.6±6.8, p=0.36).
We investigated the 176 subjects with osteopenia/
osteoporosis according to fracture history status. A total of
101 subjects had reported fractures after age 50 and/or mod-
erate and/or severe VFA-verified vertebral fractures whereas
46 subjects had no fractures. Thus, a total of 29 subjects with
only mild vertebral fractures were excluded from the analyses.
Using independent samples t test, there were no differences
between fractured subjects and controls (n=46) in crude
BMSi (76.5±7.4 vs. 75.3±8.0, p=0.40) or operator and
weight-adjusted BMSi (76.1±6.9 vs. 75.1±7.0, p=0.43).
Fractured women had lower aBMD of the total hip (0.748±
0.094 vs. 0.799±0.080, p=0.002) and the femur neck (0.608±
0.076 vs. 0.647±0.056, p=0.003) than controls. Including all
covariates in a logistic regressionmodel (as above), there were
no associations between BMSi and any fracture (odds ratio
(OR) 0.85 (0.57–1.26)), vertebral fractures (OR 0.60 (0.35–
1.02)), peripheral fractures (OR 1.04 (0.62–1.74)), or osteo-
porotic fractures (OR 0.71 (0.46–1.11)) but strong associa-
tions between aBMD of the total hip and femur neck for all
fractures (OR 2.42 (1.38–4.26) and OR 2.76 (1.42–5.33), re-
spectively), vertebral fractures (OR 2.93 (1.41–6.11) and OR
3.48 (1.48–8.20), respectively), peripheral fractures (OR 5.63
(2.30–13.75) and OR 4.18 (1.82–9.59), respectively), and os-
teoporotic fractures (OR 2.97 (1.52–5.80) and OR 2.79 (1.33–
5.82), respectively).
Discussion
In a population-based cohort of 211 women between 75 and
80 years of age, we could not demonstrate any difference in
BMSi between fractured and non-fractured subjects, but a
weak association between BMSi and aBMD was found. This
Table 2 BMSi according to smoking status, use of bisphosphonates, or p.o. glucocorticoids
BMSi BMSi BMSi BMSi
Current user Non-user p Ever user Never user p
Smoking 75.7±8.9 (n=18) 75.6±7.5 (n=193) 0.95 75.0±8.0 (n=89) 76.1±7.3 (n=122) 0.34
Bisphosphonates 77.1±5.7 (n=18) 75.5±7.7 (n=193) 0.28 77.8±7.7 (n=40) 75.1±7.5 (n=171) 0.05
Glucocorticoids (p.o.) 81.7±7.5 (n=5) 75.5±7.5 (n=206) 0.16 78.0±7.8 (n=20) 75.4±7.5 (n=191) 0.17
Means and standard deviations are shown. Differences between groups evaluated using independent samples t test
Table 1 Characteristics of the study subjects and BMSi associations
Subjects (n=211) BMSi r p Weight and operator-adjusted BMSi
β
p Fully adjusted BMSi
β
p
Age (years) 78.3±1.1 −0.07 0.35
Weight (kg) 69.1±12.6 −0.14 0.04
Height (cm) 161.1±5.8 0.04 0.56
Walking speed (m/s) 2.0±0.4 0.04 0.59
Calcium intake (mg/day) 743±407 0.03 0.67
Total hip aBMD (g/cm2) 0.796±0.112 0.05 0.51 0.14 0.04 0.13 0.06
Femur neck aBMD (g/cm2) 0.652±0.100 0.05 0.45 0.13 <0.05 0.13 0.06
Lumbar spine aBMD (g/cm2) 0.934±0.161 0.06 0.36 0.14 <0.05 0.13 0.06
Radius aBMD (g/cm2) 0.575±0.078 0.08 0.22 0.17 0.02 0.16 0.03
Mean values and standard deviations are shown in the first column, and the second column displays r-coefficients calculated using Pearson correlation.
Unstandardized β were calculated using linear regression models with BMS as predictor, including weight and operator as independent variables in the
fourth column. The fully adjusted model also included age, height, walking speed, calcium intake, current smoking, and current use of bisphosphonates
and oral glucocorticoids as covariates
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is in contrast to the only previously published study on prev-
alent fractures using the OsteoProbe, where Malgo et al. re-
ported that BMSi was associated with prevalent fragility frac-
ture in men and women with osteopenia or osteoporosis [12].
As a subanalysis, we also investigated the osteopenic/
osteoporotic women of our cohort, but we could not reveal
any reduction in BMSi in regard to prevalent fracture. In con-
trast, also Diez-Perez found significant differences in
microindentation values between hip fracture and non-
fracture cases although with a different device and in a cyclic
loading challenge testing [8].
We report an association between weight and BMSi, and
when adjusting for weight, BMSi was positively associated
with aBMD at the hip, spine, and radius. In contrast, Malgo
et al. found no correlations between BMSi and aBMD [12].
Sosa et al. demonstrated that Norwegian women had higher
aBMD but lower BMSi than Spanish women [14], while no
association was seen between aBMD and BMSi. In the pres-
ent study, the cohort of women was quite homogenous with a
narrower age span but had a higher mean age than was the
case in the examined populations in the previously per-
formed studies. Given that the function of the mineral is
to strengthen the collagen composite and that the actual
bone strength is highly correlated with DXA-derived
aBMD, it seems plausible that BMSi should in some
way be correlated with aBMD [19].
It has not yet been well characterized what BMSi actually
measures, in terms of bone material properties. We speculate
that the cortical bone would be deteriorated, with a high age-
dependent cortical porosity in our cohort of older women,
which would then be expected to negatively influence BMSi
in the cortical bone. Therefore, peripheral fractures, to which
cortical bone probably contributes the most, were also inves-
tigated in relation to BMSi. Surprisingly, there was no
Table 3 Associations between anthropometric variables, aBMD, and BMSi
No fracture All fractures Vertebral fractures Peripheral fractures Osteoporotic fractures
n=63 n=117 n=58 n=53 n=89
BMSi 75.7±7.9 76.1±7.4 77.1±7.5 75.5±7.0 76.7±7.3
BMSi, adjusted for weight and operator 75.7±7.1 76.0±6.9 76.9±6.9 75.6±6.7 76.7±6.8
Age (years) 78.2±1.1 78.3±1.1 78.2±1.1 78.4±1.0 78.3±1.1
Weight (kg) 70.2±13.4 68.6±12.9 66.9±13.2 68.7±12.8 68.3±13.2
Height (cm) 162.1±5.7 160.6±6.2 160.3±6.0 160.5±6.1 160.2±6.4
Walking speed (m/s) 2.0±0.4 2.0±0.4 2.0±0.4 2.0±0.5 2.0±0.4
Calcium intake (mg/day) 682±362 773±443 783±465 861±454* 813±461
Total hip aBMD (g/cm2) 0.843±0.109 0.773±0.114*** 0.765±0.112*** 0.751±0.123*** 0.770±0.114***
Femur neck aBMD (g/cm2) 0.691±0.094 0.638±0.104*** 0.636±0.106** 0.627±0.120** 0.639±0.104**
Lumbar spine aBMD (g/cm2) 0.960±0.148 0.912±0.167 0.917±0.171 0.881±0.153** 0.915±0.171
Radius aBMD (g/cm2) 0.581±0.085 0.571±0.075 0.572±0.081 0.554±0.078 0.570±0.077
Means and standard deviations are shown. Differences between the values of the first column and the remaining columns were investigated using
independent samples t test. All fracture cases represent fractures after the age of 50, except VFA-verified vertebral fractures, which were not datable.
Vertebral fractures refer to moderate and severe fractures verified by VFA. Cases with only mild vertebral fractures were excluded
*p<0.05, **p<0.01, ***p<0.001
Table 4 Fracture history is associated with aBMD but not BMSi
All fractures Vertebral fractures Peripheral fractures Osteoporotic fractures
n=117 n=58 n=53 n=89
OR (CI) OR (CI) OR (CI) OR (CI)
BMSi 0.89 (0.63–1.27) 0.67 (0.43–1.05) 0.96 (0.61–1.50) 0.74 (0.51–1.09)
Total hip aBMD 1.98 (1.34–2.93) 1.95 (1.20–3.17) 2.71 (1.57–4.67) 1.92 (1.26–2.93)
Femur neck aBMD 1.73 (1.19–2.51) 1.60 (1.00–2.55) 1.79 (1.12–2.87) 1.61 (1.06–2.43)
Lumbar spine aBMD 1.30 (0.92–1.84) 1.15 (0.75–1.76) 1.87 (1.13–3.09) 1.22 (0.84–1.77)
Radius aBMD 1.06 (0.74–1.51) 0.88 (0.57–1.36) 1.41 (0.89–2.21) 0.98 (0.66–1.46)
Results presented as odds ratios (OR) and confidence intervals (CI) for prevalent fracture per standard deviation decrease in BMSi and aBMD.
Associations were tested using logistic regression, including operator (only for BMSi), age, weight, height, walking speed, calcium intake, current
smoking, and current use of bisphosphonates and oral glucocorticoids. All fracture cases represent fractures after the age of 50, except VFA-verified
vertebral fractures, which were not datable. Vertebral fractures refer to moderate and severe fractures verified by VFA. Cases with only mild vertebral
fractures were excluded
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tendency of any association between BMSi and these frac-
tures, indicating that BMSi does not reflect bone fragility in
our particular study population. In some clinical situations,
bone material properties may play a more predominant role
in decreasing bone strength, like younger individuals with
fragility fractures [12], diabetes [20], or incident use of gluco-
corticoids [21]; BMSi testing could perhaps be of greater
value.
A strength of the present study is that we have investigated
the associations between BMSi, prevalent fractures, and
aBMD in the largest sample of women so far. In contrast to
previous studies, our sample was population-based and not
selected due to an event such as a recent prior fracture. It could
be argued that using a larger, more homogenous and
population-based sample, the risk of bias due to confounders
affecting the BMSi associations would be smaller than in
case-control studies.
There are some limitations in this study. Firstly, there were
four different operators conducting the microindentation test-
ing. To minimize the possible negative effect of the outcome,
all operators trained together before starting the study, and in
the first 100 subjects, at least two operators were present dur-
ing the measurement of which one was observing and
commenting on the technique if necessary. We also found that
the mean BMSi for each operator differed which could not
only be due to differences in the characteristics of the women
measured but also due to differently performedmeasurements.
To ensure that any possible bias introduced by operator and
the measuring technique would be accounted for, we adjusted
for operator using dummy variables in the regression models
used although some potential effect on the results cannot
completely be ruled out. Another weakness is that we have
not been able to verify the self-reported fractures, and
other previous studies have reported a significant dis-
crepancy between reported and X-ray-verified fractures
[22, 23]. Furthermore, our used definition of osteoporot-
ic fractures was based only on skeletal site, and we
included all reported fractures, irrespective of trauma
type, which could have attenuated possible associations.
However, we also included VFA-verified vertebral frac-
tures, and in the separate analysis on these subjects, no
association between fractures and BMSi was seen. Ar-
guing against errors introduced by fracture misclassifi-
cation (i.e., fractures being self-reported), we found
clear associations with aBMD, indicating that also the
self-reported fractures were indeed due to presence of
skeletal fragility. We lacked information concerning the
nature of the trauma causing the fracture, which may
infer that several of the reported fractures are actually
caused by moderate or even severe trauma. There are,
however, studies reporting that also fractures caused by
moderate and severe trauma are associated to bone fra-
gility in a similar way as low-energy fractures are [24,
25]. We tested association between BMSi and several
aBMD sites, introducing uncertainty of multiple testing,
although the aBMD variables were intercorrelated (fem-
oral neck vs. total hip BMD (r=0.83) and radius aBMD
vs. total hip (r=0.65)). The weak associations found
between BMSi and aBMD would not remain significant
if adjustments were made for multiple comparisons.
Since we are unable to corroborate the previously pub-
lished reports finding associations between BMSi and preva-
lent fracture, we performed a very extensive evaluation of our
BMSi protocol and analysis. We performed as much as 30
dual measurements, using more indentations than other inves-
tigators, and could demonstrate a low intraobserver CV of
3.2 %. Farr et al., however, reports an even lower
intraobserver CV (precision error) of 1.65 %, calculated on
ten subjects [13], while Malgo reports a CVof <10 %, without
presenting the method of calculation [12]. In the study com-
paring Norwegian and Spanish women, a CVof 9.1 % includ-
ing 16 subjects was reported [14]. We also thoroughly inves-
tigated the interobserver CV found to be 5.2 %, which is still
low in comparison to other investigators. Thus, our rather low
CVs obtained with high standards support that we have con-
ducted the method accurately and that our observations are
likely not the results of insufficiently performed
microindentations.
The number of moderate and severe vertebral fractures was
high in the present study, corresponding to a prevalence of
27.5 % in the studied cohort, which is in line with high prev-
alence numbers previously reported for older Swedish women
[26], who have among the highest fracture risk in the world
[27, 28].
We conclude that in a population-based cohort of older
Swedish women, there were no associations between preva-
lent fracture and BMSi. We also demonstrate a weak associa-
tion between weight-adjusted BMSi and aBMD of relevant
skeletal sites. As a result of our study not being able to cor-
roborate a previous study that has found associations between
prevalent fractures and BMSi, we believe that further studies
are needed to establish if BMSi can aid in characterizing skel-
etal fragility and improve fracture prediction, in particular in
older populations.
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